Cefoxitin - Revision history

Danbot: Restore original dosing content alongside dynamic SMW tables

2026-03-20T02:38:44Z

Restore original dosing content alongside dynamic SMW tables

← Older revision		Revision as of 02:38, 20 March 2026
Line 7:		Line 7:

	==Adult Dosing==		==Adult Dosing==
			*1-2g IV q6-8h


	===Indications by Disease===		===Indications by Disease===
	{{#ask: [[Has DrugName::Cefoxitin]] [[Has Population::Adult]]		{{#ask: [[Has DrugName::Cefoxitin]] [[Has Population::Adult]]
	\|?Treats disease=Disease		\|?Treats disease=Disease
	\|?Has Dose=Dose		\|?Has Dose=Dose
	\|?Has Context=Context		\|?Has Context=Context
	\|format=table		\|format=table
	\|limit=50		\|limit=50
	\|mainlabel=-		\|mainlabel=-
	\|headers=show		\|headers=show
	\|sort=Treats disease		\|sort=Treats disease
	}}		}}

	==Pediatric Dosing==		==Pediatric Dosing==
			*<3 months old: Safety & efficacy not established
			*>3 months old: 80-160 mg/kg/day IV divided q4-6hr; higher dosages should be used for more severe or serious infections


	===Indications by Disease===		===Indications by Disease===
	{{#ask: [[Has DrugName::Cefoxitin]] [[Has Population::Pediatric]]		{{#ask: [[Has DrugName::Cefoxitin]] [[Has Population::Pediatric]]
	\|?Treats disease=Disease		\|?Treats disease=Disease
	\|?Has Dose=Dose		\|?Has Dose=Dose
	\|?Has Context=Context		\|?Has Context=Context
	\|format=table		\|format=table
	\|limit=50		\|limit=50
	\|mainlabel=-		\|mainlabel=-
	\|headers=show		\|headers=show
	\|sort=Treats disease		\|sort=Treats disease
	}}		}}

2026-03-20T01:52:40Z

Replace manual dosing with dynamic SMW tables (Adult + Pediatric)

← Older revision		Revision as of 01:52, 20 March 2026
Line 7:		Line 7:

	==Adult Dosing==		==Adult Dosing==
	*1-~~2g IV q6-8h~~		===Indications by Disease===
			{{#ask: [[Has DrugName::Cefoxitin]] [[Has Population::Adult]]
			\|?Treats disease=Disease
			\|?Has Dose=Dose
			\|?Has Context=Context
			\|format=table
			\|limit=50
			\|mainlabel=-
			\|headers=show
			\|sort=Treats disease
			}}

	==Pediatric Dosing==		==Pediatric Dosing==
	*<3 months old: ~~Safety & efficacy not established~~		===Indications by Disease===
	*>3 months old: 80-~~160 mg/kg/day IV divided q4-6hr; higher dosages should be used for more severe or serious infections~~		{{#ask: [[Has DrugName::Cefoxitin]] [[Has Population::Pediatric]]
			\|?Treats disease=Disease
			\|?Has Dose=Dose
			\|?Has Context=Context
			\|format=table
			\|limit=50
			\|mainlabel=-
			\|headers=show
			\|sort=Treats disease
			}}

	==Special Populations==		==Special Populations==

2025-07-18T16:10:09Z

← Older revision		Revision as of 16:10, 18 July 2025
Line 1:		Line 1:
	==General==		==General==
	*Type: ~~Second~~ generation [[Is DrugClass::cephalosporin]]		*Type: [[Is Generation::2nd generation]] [[Is DrugClass::cephalosporin]]
	*Dosage Forms: powder for injection		*Dosage Forms: powder for injection
	*Dosage Strengths: 1g, 2g, 10g		*Dosage Strengths: 1g, 2g, 10g

2025-07-18T14:50:34Z

← Older revision		Revision as of 14:50, 18 July 2025
Line 1:		Line 1:
	==General==		==General==
	*Type: Second generation [[cephalosporin]]		*Type: Second generation [[Is DrugClass::cephalosporin]]
	*Dosage Forms: powder for injection		*Dosage Forms: powder for injection
	*Dosage Strengths: 1g, 2g, 10g		*Dosage Strengths: 1g, 2g, 10g

2019-09-19T21:56:04Z

← Older revision		Revision as of 21:56, 19 September 2019
Line 7:		Line 7:

	==Adult Dosing==		==Adult Dosing==
			*1-2g IV q6-8h

	==Pediatric Dosing==		==Pediatric Dosing==
			*<3 months old: Safety & efficacy not established
			*>3 months old: 80-160 mg/kg/day IV divided q4-6hr; higher dosages should be used for more severe or serious infections

	==Special Populations==		==Special Populations==
	*Pregnancy:		*Pregnancy: Category B
	*Lactation:		*Lactation: Minimal excretion in breast milk, limited data on affect to infant
	*Renal Dosing		*Renal Dosing
	**~~Adult~~		**CrCl 30-50 mL/min: 1-2 g q8-12hr
	**~~Pediatric~~		**CrCl 10-30 mL/min: 1-2 g q12-24hr
	*~~Hepatic Dosing~~		**CrCl 5-9 mL/min: 500 mg-1 g q24-28hr
	**~~Adult~~		**CrCl <5 mL/min: 500 mg-1 g q24-48hr
	**Pediatric		*Hepatic Dosing: not defined

	==Contraindications==		==Contraindications==
	*Allergy to class/drug		*Allergy to class/drug
			*Neonates

	==Adverse Reactions==		==Adverse Reactions==
Line 27:		Line 31:

	===Common===		===Common===
			*Diarrhea
			*Anemia, thrombocytopenia, transient leukopenia
			*Elevated Cr/BUN
			*Elevated LFTs

	==Pharmacology==		==Pharmacology==
Line 161:		Line 169:
	==References==		==References==
	<references/>		<references/>
	[[Category:Pharmacology]]		[[Category:Pharmacology]] [[Category:ID]]

2019-01-18T23:15:23Z

General

2017-10-23T10:11:53Z

Text replacement - "==References== <references/>" to "==References== <references/>"

2017-10-13T18:02:37Z

Pharmacology: edited half life, excretion, mechanism of action

← Older revision		Revision as of 18:02, 13 October 2017
Line 29:		Line 29:

	==Pharmacology==		==Pharmacology==
	*Half-life:		*Half-life: 45-60 min
	*Metabolism:		*Metabolism:
	*Excretion:		*Excretion: Unchanged in urine (85%)
	*Mechanism of Action:		*Mechanism of Action: Inhibits bacterial cell wall synthesis

	==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>==		==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>==

2017-10-13T18:01:18Z

edited dosage forms, strengths, routes of administration

← Older revision		Revision as of 18:01, 13 October 2017
Line 1:		Line 1:
	==General==		==General==
	*Type: Second generation [[cephalosporin]]		*Type: Second generation [[cephalosporin]]
	*Dosage Forms:		*Dosage Forms: powder for injection
			*Dosage Strengths: 1g, 2g, 10g
			*Route of Administration: IV
	*Common Trade Names:		*Common Trade Names:

2017-09-13T06:41:12Z

Text replacement - "==Source==" to "==References=="